Moderate to Severe Traumatic Brain InjuryREHAB-MDTNCT03874416
Cognitive Rehabilitation of Working Memory After Moderate to Severe Traumatic Brain Injury
A study testing Specific rehabilitation and Non-specific rehabilitation in people with Moderate to Severe Traumatic Brain Injury, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
Trial summary
The study aims to demonstrate improvement of daily life functioning and improvement of cognitive tests in post traumatic brain injury (TBI) patients suffering from working memory deficit, by a 3-month specific cognitive rehabilitation program, in comparison with patients with usual non-specific rehabilitation of same… Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Moderate to Severe Traumatic Brain Injury
- What is being tested?
- Specific rehabilitation and Non-specific rehabilitation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 54 participants
- Where
- 1 siteFrance
- Study dates
- 25 Jan 2021to Apr 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Aged between 18 - 65 years;
- Moderate to severe TBI (Glasgow score between 3 and 12 in the 24 first hours);
- At least 6 months following TBI;
- Complaint related to working memory in daily life (scale > 29 of questionnaire of complaint on working memory (WMQ), and established deficit of working memory by one of the following criteria:
- Index of working memory (IWM) of Wechsler Adult Intelligence Scale (WAIS-IV) < 85 or p < .05 between IWM and one of the WAIS-IV index;
- Less than 70% correct responses on Brown-Peterson tasks test in the verbal modality with an interfering task as mental calculation;
Show all 14Show fewer
- Less than 89% correct responses on Brown-Peterson tasks test in the verbal modality with an interfering task of articulatory suppression;
- Less than 70% correct responses on Brown-Peterson tasks test in the visuospatial modality with an interfering motor task.
- Prior medical examination;
- Correct vision after visual acuity correction;
- Stable neurological or psychoactive treatment for at least 4 weeks, if applicable;
- Able to move to the center where rehabilitation will be performed;
- Covered by a health insurance;
- Signed consent of patient or of the guardian.
Who cannot join
- History of central nervous system disorder, or history of psychological disorder or substance abuse;
- Prior specific cognitive rehabilitation of working memory;
- Instrumental activities disabilities, cognitive disorder, behavioural disorders or major psychiatric disorder;
- Major anxio-depressive syndrome or present psychiatric disorder which can interfere with experimental procedure or measured variables;
- Pregnant or breastfeeding woman.
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
Physical medicine and rehabilitation department, Raymond Poincaré Hospital
Garches, Hauts-de-seine, 92380
Claire Vallat-Azouvi, PhD, + 33 1 47 10 76 47, claire.vallat-azouvi@univ-paris8.fr
Philippe Azouvi, MD, PhD, + 33 1 47 10 70 78, philippe.azouvi@aphp.fr
About this study
Official title: A Randomized Controlled Trial of Cognitive Rehabilitation of Working Memory After Moderate to Severe Traumatic Brain Injury
The study aims to demonstrate improvement of daily life functioning and improvement of cognitive tests in post traumatic brain injury (TBI) patients suffering from working memory deficit, by a 3-month specific cognitive rehabilitation program, in comparison with patients with usual non-specific rehabilitation of same duration.
As secondary objectives, the study aims to:
- demonstrate improvement of specific neuropsychological tests of working memory;
- demonstrate improvement of non-specific tasks involving working memory;
- assess the evolution in not-targeted domains by the specific rehabilitation, which would give evidence of a global cognitive stimulation effect;
- demonstrate improvement of social integration ability and quality of life;
- demonstrate persistence of effects at 3 months and 6 months after the end of treatment;
- demonstrate the acceptability, the tolerance and the feasibility of rehabilitation.
Read the detailed description
Working memory is an essential cognitive function which allows to store briefly and treat simultaneous informations, but is often altered after a moderate to severe TBI. This alteration results in disabilities and social integration difficulties in the post TBI patients. The study team had developped a standardized and hierarchized rehabilitation program of working memory. Several experiments have shown the efficacy of the program which is now used in routine care by speech-language pathologists and neuropsychologists. However it is necessary to provide a robust demonstration of its efficacy in improving function in daily life.
This randomized multicenter study will be performed in 6 centers in the area of Île-de-France. 54 patients will be randomized 1:1 to receive either specific rehabilitation of working memory or non-specific rehabilitation. A 10-month follow-up is planned for patients of the two arms.
- Being tested
- Specific rehabilitation, Non-specific rehabilitation
- Keywords
- moderate to severe traumatic brain injury, cognitive rehabilitation, working memory, daily life function, Working Memory Questionnaire, WMQ, Brown-Peterson test
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Specific rehabilitationOther
Experimental rehabilitation of working memory:
3 sessions per week during 3 months, for a total 36 sessions.
Non-specific rehabilitationOther
Usual non-specific rehabilitation treatment for moderate to severe TBI in healthcare facilities: 2-3 sessions per week for 3 months.
| Study group | Role | What they receive |
|---|---|---|
| Specific rehabilitation of working memory | Experimental | Specific rehabilitation of working memory according to hierarchized rehabilitation. Receives: Other: Specific rehabilitation |
| Control group | Active comparator | Non-specific rehabilitation of working memory, usual therapy. Receives: Other: Non-specific rehabilitation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportions of simultaneous responders
A patient will be considered as a responder if he improves simultaneously on the Working Memory Questionnaire (WMQ) and the Brown-Peterson Task.
Proportions will be calculated of patients simultaneously improving on the Working Memory Questionnaire (WMQ) and the Brown-Peterson Task:
- increase of at least 12 points on WMQ scale,
- at least 13% score improvement on the verbal or visuo-spatial Brown-Peterson Task.
Measured: 3 months after the first rehabilitation session
Secondary outcomes (19)
Working Memory Questionnaire during rehabilitation program
The Working Memory Questionnaire (WMQ), an auto-questionnaire elaborated by the study team, will be used.
The WMQ is a self-administered scale, addressing three dimensions of working memory: short-term storage, attention, and executive control.
It is a self-assessment questionnaire comprising 30 questions scored on a five-point Likert scale, ranging from 0 ("no problem at all") to 4 ("very severe problem in everyday life"). The total score will be used.
Measured: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Working memory span tasks
Measured: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Verbal and visuospatial working memory.
Measured: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
n-back task
Measured: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Brown-Peterson Visual.
Measured: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
reading span task.
Measured: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Working Memory Index (WISC-IV).
Measured: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
divided attention task
Measured: At baseline, 3 months, 6 months and 9 months
Arithmetic resolution
Non-specific tasks involving working memory: arithmetic resolution ability by WAIS index
Measured: At baseline, 3 months and 6 months
Non-targeted cognitive measurements
Executive functions will be assessed.
Measured: At baseline, 3 months and 6 months
Non-targeted cognitive measurements
Long-term memory will be assessed.
Measured: At baseline, 3 months and 6 months
Non-targeted cognitive measurements
The speed of treatment will be assessed.
Measured: At baseline, 3 months and 6 months
Social functioning assessement
Assessed by Manual for Sydney Psychosocial Reintegration Scale (SPRS)
Measured: At baseline, 3 months, 6 months and 9 months
Quality of life assessment
Assessed by Qolibri scale
Measured: At baseline, 3 months, 6 months and 9 months
Quality of life assessment
Assessed by EQ5D-5
Measured: At baseline, 3 months, 6 months and 9 months
Acceptability
Compliance of rehabilitation program: duration of training of speech-language pathologist and psychologist to the rehabilitation program.
Measured: At baseline, 3 months and 6 months
Acceptability
Compliance of rehabilitation program: duration of session.
Measured: At baseline, 3 months and 6 months
Acceptability
Compliance of rehabilitation program: patient's satisfaction of care (Client Satisfaction Questionnaire (CSQ-8)).
Measured: At baseline, 3 months and 6 months
Acceptability
Compliance of rehabilitation program: presence during rehabilitation session of working memory.
Measured: At baseline, 3 months and 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Mar 2019
- Study start25 Jan 2021
- Primary completionApr 2025 (estimated)
- Study completionApr 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Moderate to Severe Traumatic Brain InjuryStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Single blind trial with 2 parallel arms: Specific rehabilitation of working memory vs. non-specific rehabilitation
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 54 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Claire Vallat-Azouvi, PhD, Principal investigator, Laboratoire LPN, EA2027-Université Paris 8, and Hôpital Raymond Poicaré-Antenne UEROS-UGECAMIDFPhilippe Azouvi, MD, PhD, Study director, Service Médecine Physique et de Réadaptation, Hôpital Raymond Poicaré, 92380 Garches
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03874416
- Sponsor's protocol ID
- K160902J
- Other IDs
- PHRIP-16-0380, 2018-A02713-52
- Acronym
- REHAB-MDT
- Status last verified
- Sep 2023
- First submitted
- 4 Feb 2019
- Last updated
- 6 Sep 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Sep 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Trial of Cognitive Rehabilitation of Working Memory After Moderate to Severe Traumatic Brain Injury
- ClinicalTrials.gov ID
- NCT03874416
- Acronym / sponsor ID
- REHAB-MDT / K160902J
- Keywords
- moderate to severe traumatic brain injury, cognitive rehabilitation, working memory, daily life function, Working Memory Questionnaire, WMQ, Brown-Peterson test
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 54 participants (estimated)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Study start
- 25 Jan 2021 (actual)
- Primary completion
- Apr 2025 (estimated)
- Study completion
- Apr 2025 (estimated)
- First posted
- 14 Mar 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study aims to demonstrate improvement of daily life functioning and improvement of cognitive tests in post traumatic brain injury (TBI) patients suffering from working memory deficit, by a 3-month specific cognitive rehabilitation program, in comparison with patients with usual non-specific rehabilitation of same duration.
As secondary objectives, the study aims to:
- demonstrate improvement of specific neuropsychological tests of working memory;
- demonstrate improvement of non-specific tasks involving working memory;
- assess the evolution in not-targeted domains by the specific rehabilitation, which would give evidence of a global cognitive stimulation effect;
- demonstrate improvement of social integration ability and quality of life;
- demonstrate persistence of effects at 3 months and 6 months after the end of treatment;
- demonstrate the acceptability, the tolerance and the feasibility of rehabilitation.
Detailed description
Working memory is an essential cognitive function which allows to store briefly and treat simultaneous informations, but is often altered after a moderate to severe TBI. This alteration results in disabilities and social integration difficulties in the post TBI patients. The study team had developped a standardized and hierarchized rehabilitation program of working memory. Several experiments have shown the efficacy of the program which is now used in routine care by speech-language pathologists and neuropsychologists. However it is necessary to provide a robust demonstration of its efficacy in improving function in daily life.
This randomized multicenter study will be performed in 6 centers in the area of Île-de-France. 54 patients will be randomized 1:1 to receive either specific rehabilitation of working memory or non-specific rehabilitation. A 10-month follow-up is planned for patients of the two arms.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Single blind trial with 2 parallel arms: Specific rehabilitation of working memory vs. non-specific rehabilitation
| Arm | Type | Receives |
|---|---|---|
| Specific rehabilitation of working memory | Experimental | Other: Specific rehabilitationSpecific rehabilitation of working memory according to hierarchized rehabilitation. |
| Control group | Active comparator | Other: Non-specific rehabilitationNon-specific rehabilitation of working memory, usual therapy. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (14 listed)
- Aged between 18 - 65 years;
- Moderate to severe TBI (Glasgow score between 3 and 12 in the 24 first hours);
- At least 6 months following TBI;
- Complaint related to working memory in daily life (scale > 29 of questionnaire of complaint on working memory (WMQ), and established deficit of working memory by one of the following criteria:
- Prior medical examination;
Key exclusion criteria (5 listed)
- History of central nervous system disorder, or history of psychological disorder or substance abuse;
- Prior specific cognitive rehabilitation of working memory;
- Instrumental activities disabilities, cognitive disorder, behavioural disorders or major psychiatric disorder;
- Major anxio-depressive syndrome or present psychiatric disorder which can interfere with experimental procedure or measured variables;
- Pregnant or breastfeeding woman.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Specific rehabilitationExperimental rehabilitation of working memory: 3 sessions per week during 3 months, for a total 36 sessions. | Other | Specific rehabilitation of working memory |
| Non-specific rehabilitationUsual non-specific rehabilitation treatment for moderate to severe TBI in healthcare facilities: 2-3 sessions per week for 3 months. | Other | Control group |
Primary outcome
Proportions of simultaneous responders
Time frame: 3 months after the first rehabilitation session
A patient will be considered as a responder if he improves simultaneously on the Working Memory Questionnaire (WMQ) and the Brown-Peterson Task. Proportions will be calculated of patients simultaneously improving on the Working Memory Questionnaire (WMQ) and the Brown-Peterson Task: * increase of at least 12 points on WMQ scale, * at least 13% score improvement on the verbal or visuo-spatial Brown-Peterson Task.
19 secondary outcomes
Working Memory Questionnaire during rehabilitation program
Time frame: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Time frame: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Time frame: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Time frame: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Time frame: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Time frame: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Time frame: At baseline, 3 months, 6 months and 9 months
Cognitive task of working memory
Time frame: At baseline, 3 months, 6 months and 9 months
Arithmetic resolution
Time frame: At baseline, 3 months and 6 months
Non-targeted cognitive measurements
Time frame: At baseline, 3 months and 6 months
Non-targeted cognitive measurements
Time frame: At baseline, 3 months and 6 months
Non-targeted cognitive measurements
Time frame: At baseline, 3 months and 6 months
Social functioning assessement
Time frame: At baseline, 3 months, 6 months and 9 months
Quality of life assessment
Time frame: At baseline, 3 months, 6 months and 9 months
Quality of life assessment
Time frame: At baseline, 3 months, 6 months and 9 months
Acceptability
Time frame: At baseline, 3 months and 6 months
Acceptability
Time frame: At baseline, 3 months and 6 months
Acceptability
Time frame: At baseline, 3 months and 6 months
Acceptability
Time frame: At baseline, 3 months and 6 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Sep 2023.
- Individual participant dataSharing planned: No
Related trials for Moderate to Severe Traumatic Brain Injury
Not yet recruitingPhase 2/3
Valproic AcId for Traumatic BRAin INjury Trial
Moderate Traumatic Brain Injury (TBI), Severe Traumatic Brain Injury
Not yet recruitingObservational study
Blood NfL and Functional Outcomes After Moderate-to-Severe TBI
Traumatic Brain Injury
RecruitingPhase 4
Methylprednisolone for Moderate to Severe Traumatic Brain Injury
Traumatic Brain Injury
Active, not recruitingObservational study
Prognostic Model for Predicting Outcome After Moderate to Severe Paediatric Traumatic Brain Injury
Traumatic Brain Injury (TBI)
RecruitingPhase 1/2
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
Traumatic Brain Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Claire Vallat-Azouvi, PhD principal investigator
Laboratoire LPN, EA2027-Université Paris 8, and Hôpital Raymond Poicaré-Antenne UEROS-UGECAMIDF
Philippe Azouvi, MD, PhD study director
Service Médecine Physique et de Réadaptation, Hôpital Raymond Poicaré, 92380 Garches
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Specific rehabilitation and Non-specific rehabilitation in people with Moderate to Severe Traumatic Brain Injury, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 14 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Claire Vallat-Azouvi, PhD (+33 1 47 10 76 47, claire.vallat-azouvi@univ-paris8.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportions of simultaneous responders (time frame: 3 months after the first rehabilitation session). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2023.